High mortality rate of (NZW x BXSB)F1 mice induced by administration of lipopolysaccharide attributes to high production of tumour necrosis factor-α by increased numbers of dendritic cells

Clinical and Experimental Immunology

Volumn 154, Issue 2, 2008, Pages 285-293

  Koike Kiriyama, N ^a   Adachi, Y ^a   Iwasaki, M ^a   Amou, Y ^b   Shigematsu, A ^a   Koike, Y ^a   Minamino, K ^a   Mukaide, H ^a   Shi, M ^a   Yanai, S ^a   Matsumura, M ^a   Ikehara, S ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b Amou Clinic   (Japan)

Author keywords

(NZW x BXSB)F1 mice (W BF1 mice); Lipopolysaccharide; TNF ; Toll like receptor

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; HISTOLOGY; MACROPHAGE; MALE; MONOCYTE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALS; AUTOIMMUNE DISEASES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; SURVIVAL ANALYSIS; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53349089993     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03759.x     Document Type: Article

References (26)

1. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002 20 : 197 216.
2. Beutler B, Riestschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003 3 : 169 76.
3. Hoshino K, Takeuchi O, Kawai T et al. Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the lps gene product. J Immunol 1999 162 : 3749 52.
4. Morrison DC, Ryan JL. Bacterial endotoxins and host immune responses. Adv Immunol 1979 28 : 293 450.
5. Baumann H, Gauldie J. Acute phase response. Immunol Today 1994 15 : 74 80.
6. Hang LM, Izui S, Dixon FJ NZW × BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med 1981 154 : 241 6.
7. Adachi Y, Inaba M, Amoh Y et al. Effect of bone marrow transplantation on anti-phospholipid antibody syndrome in murine lupus mice. Immunobiology 1994 192 : 218 30.
8. Hang L, Stephens-Larson P, Henry JP, Dixon FJ. The role of hypertension in the vascular disease and myocardial infarcts associated with murine systemic lupus erythematosus. Arthritis Rheum 1983 26 : 1340 5.
9. Oyaizu N, Yasumizu R, Miyama-Inaba M et al. (NZW × BXSB)F1 mouse, a new animal model of idiopathic thrombocytopenia purpura. J Exp Med 1998 167 : 2017 22.
10. Adachi Y, Taketani S, Toki J et al. Marked increase in number of dendritic cells in autoimmune-prone (NZW × BXSB)F1 mice with age. Stem Cells 2002 20 : 61 72.
11. Adachi Y, Taketani S, Oyaizu H, Ikebukuro K, Tokunaga R, Ikehara S. Apoptosis of colorectal adenocarcinoma induced by 5-FU and/or IFN-gamma through caspase 3 and caspase 8. Int J Oncol 1999 15 : 1191 6.
12. Ferrero I, Held W, Wilson A, Tacchini-Cottier F, Radtke F, Macdonald HR. Mouse CD11c(+) B220(+) Gr1(+) plasmacytoid dendritic cells develop independently of the T-cell lineage. Blood 2002 100 : 2852 7.
13. Takeuchi O, Hoshino K, Akira S. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000 165 : 5392 6.
14. Adachi Y, Inaba M, Inaba K, Than S, Kobayashi Y, Ikehara S. Analyses of thymic abnormalities in autoimmune-prone (NAW×BXSB)F1 mice. Immunobiology 1993 188 : 340 54.
15. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Dyke TV, Bancherau J. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 2001 167 : 5067 76.
16. Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999 189 : 1777 82.
17. Akashi S, Shimazu R, Ogata H et al. Cell surface expression and lipopolisaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000 164 : 3471 5.
18. De Wit DTonon S, Olislagers V, Goriely S, Boutriaux M, Goldman M, Willems F. Impaired responses to Toll-like receptor 4 and Toll-like receptor 3 ligand in human cord blood. J Autoimmun 2003 21 : 277 81.
19. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr., Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002 110 : 191 202.
20. Janssens S, Burns K, Tschopp J, Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-κB activation by alternative splicing of MyD88. Curr Biol 2002 12 : 467 71.
21. Nakagawa R, Naka T, Tsutsui H et al. SOCS-1 participates in negative regulation of LPS responses. Immunity 2002 17 : 677 87.
22. Sekine Y, Yumioka T, Yamamoto T et al. Modulation of Toll-like receptor 4 signaling by a novel adaptor protein STAP-2 in macrophages. J Immunol 2006 176 : 380 9.
23. Chen Y-S, Yang Y-H, Lin Y-T, Chiang B-L. Risk of infection in hospitalized children with systemic lupus erythematosus: a 10-year follow-up. Clin Rheumatol 2004 23 : 235 8.
24. Kim W, Min J, Lee S, Park S, Kim M. Causes of death in Korea patients with systemic lupus erythematosus: a single center retrospective study. Clin Exp Rheumatol 1999 17 : 539 45.
25. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992 356 : 314 17.
26. Bone RC. Why sepsis trials fail. JAMA 1996 276 : 565 6.